Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?
Indian markets moved higher in an ipo & listings development.
30 Sept 2026 · Economic Times Markets, ET Stocks
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600 target price, implying 27% upside from Tuesday’s close and nearly 98% above its Rs 807 IPO price. The stock had listed at a 21% premium at Rs 980.
The analysis
Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
Market context
- The immediate tone of coverage reads positive.
Related coverage
Jio IPO likely by Oct end at enterprise valuation of above ₹12 trillion
Jio IPO GMP latest price today: Grey market premium is rising day by day - Check expected price band
Wizz Financial bets on India with cross-border fintech push, eyes 2029 IPO
Reliance Jio IPO: Rs 37,700 crore mega issue, full schedule & 5 must-know details
Kanohar Electricals soars 20%; stock up 79% from IPO price in three weeks